Social connectedness in mobile gaming: how family dynamics shape children’s virtual interactions
Major readouts from the annual diabetes conference
Good morning. Remember when the streets were covered in snow? The passage of time is so wild. Below we’ve got some news to start another week.
Readouts from the annual diabetes conference
The American Diabetes Association’s annual conference in New Orleans wraps up today, after three days of data readouts, presentations, and, unexpectedly, a police interaction? Here are some highlights:
Patently imperfect
Global extent and drivers of tree cover loss quantified with high-resolution satellite data
Severe obesity in human HFpEF alters contractile protein function and organization
Competition enables rapid adaptation to a warming range edge in a model plant community
A provocative view of evolution turns 50
Single-cell spatial pharmacobiology for imaging antibody-based therapies in solid tumors
Nature Biotechnology, Published online: 08 June 2026; doi:10.1038/s41587-026-03171-8
We have developed single-cell spatial pharmacobiology (SSP), which combines in situ imaging of a systemically infused fluorescent therapeutic antibody with high-plex spatial proteomics. Applied to head and neck and pancreatic tumors from patients treated in phase 1 trials, SSP revealed marked spatial heterogeneity in antibody delivery and target engagement, which was shaped by conserved stromal barriers.
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
Nature Medicine, Published online: 08 June 2026; doi:10.1038/s41591-026-04439-x
In a whole-exome sequencing analysis, the beneficial effects of the SGLT2 inhibitor dapagliflozin in reducing the risk of future heart failure hospitalization in individuals with type 2 diabetes were markedly greater in individuals who carried a cardiomyopathy-associated genetic variant compared with noncarriers, suggesting a personalized preventative therapy based on genetic information.

